Preparative expression and purification of a nacreous protein N16 and testing its effect on osteoporosis rat model.
暂无分享,去创建一个
P. Shaw | Wei-wei Su | Pei-bo Li | Yonggang Wang | Hoi-Yan Wu | Jia-Bi Lin | Yu-Ling Liu | Hongliang Yao | Keling Cheng | Zhen-Yan Xu | Wei-peng
[1] A. Bitto,et al. Adenosine Receptor Stimulation Improves Glucocorticoid-Induced Osteoporosis in a Rat Model , 2017, Front. Pharmacol..
[2] G. Tang,et al. Reduction of Longitudinal Vertebral Blood Perfusion and Its Likely Causes: A Quantitative Dynamic Contrast-enhanced MR Imaging Study of a Rat Osteoporosis Model. , 2017, Radiology.
[3] D. Dempster,et al. Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] Hojjat Allah Abbaszadeh,et al. Evaluation of the effects of pulsed wave LLLT on tibial diaphysis in two rat models of experimental osteoporosis, as examined by stereological and real-time PCR gene expression analyses , 2016, Lasers in Medical Science.
[5] Q. Fu,et al. Curcumin alleviates glucocorticoid‐induced osteoporosis by protecting osteoblasts from apoptosis in vivo and in vitro , 2016, Clinical and experimental pharmacology & physiology.
[6] P. Shaw,et al. N16, a Nacreous Protein, Inhibits Osteoclast Differentiation and Enhances Osteogenesis. , 2016, Journal of natural products.
[7] Qiushi Wei,et al. Variance of spinal osteoporosis induced by dexamethasone and methylprednisolone and its associated mechanism , 2015, Steroids.
[8] L. Brewer,et al. Current and future treatment options in osteoporosis , 2011, European Journal of Clinical Pharmacology.
[9] Takashi Kato,et al. An Acidic Matrix Protein, Pif, Is a Key Macromolecule for Nacre Formation , 2009, Science.
[10] M. Oh,et al. Protective effect of apigenin on ovariectomy-induced bone loss in rats. , 2008, Life sciences.
[11] S. Cummings,et al. Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures. , 2007, Archives of internal medicine.
[12] H. Sievänen,et al. Three‐Point Bending of Rat Femur in the Mediolateral Direction: Introduction and Validation of a Novel Biomechanical Testing Protocol , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[13] L. Raisz. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. , 2005, The Journal of clinical investigation.
[14] D. Bauer,et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. , 2005, Endocrine reviews.
[15] Hiroshi Miyamoto,et al. The Carbonic Anhydrase Domain Protein Nacrein is Expressed in the Epithelial Cells of the Mantle and Acts as a Negative Regulator in Calcification in the Mollusc Pinctada fucata , 2005, Zoological science.
[16] Y. Hara,et al. Production of shikonin derivatives by cell suspension cultures of Lithospermum erythrorhizon , 1981, Plant Cell Reports.
[17] Mary L Bouxsein,et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. , 2003, The New England journal of medicine.
[18] M. Rhee,et al. Studies on the effects of biomedicinal agents on serum concentration of Ca2+, P and ALP activity in osteoporosis-induced rats. , 2003, Journal of veterinary science.
[19] David L. Lacey,et al. Osteoclast differentiation and activation , 2003, Nature.
[20] Daniel I. C. Wang,et al. Evaluation of different promoters and host strains for the high-level expression of collagen-like polymer in Escherichia coli. , 2003, Journal of biotechnology.
[21] Donald B. Kimmel,et al. Animal Models for in Vivo Experimentation in Osteoporosis Research , 2001 .
[22] B. Malcolm,et al. Reduced background expression and improved plasmid stability with pET vectors in BL21 (DE3). , 2000, BioTechniques.
[23] S. Manolagas,et al. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. , 2000, Endocrine reviews.
[24] T. Samata,et al. Molecular mechanism of the nacreous layer formation in Pinctada maxima. , 2000, Biochemical and biophysical research communications.
[25] J. R. Sokatch,et al. Catabolite Repression Control by Crc in 2xYT Medium Is Mediated by Posttranscriptional Regulation of bkdR Expression in Pseudomonas putida , 2000, Journal of bacteriology.
[26] R. Eastell,et al. The Use of Biochemical Markers of Bone Turnover in Osteoporosis , 2000, Osteoporosis International.
[27] E. Themeles,et al. Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis. , 1997, British journal of rheumatology.
[28] K. Chow,et al. A modified medium for efficient electrotransformation of E. coli. , 1995, Trends in genetics : TIG.
[29] C. Vorgias,et al. Cloning and expression of Saccharomyces cerevisiae copper-metallothionein gene in Escherichia coli and characterization of the recombinant protein. , 1993, European journal of biochemistry.
[30] L. Svanström. Simply osteoporosis — or multifactorial genesis for the increasing incidence of fall injuries in the elderly? The need for a scientific approach to reducing injuries , 1990, Scandinavian journal of social medicine.
[31] C. Hobbs,et al. New cloning vectors and techniques for easy and rapid restriction mapping. , 1988, Gene.